The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer

British Journal of Cancer

Volumn 106, Issue 12, 2012, Pages 2010-2015

  Richards, C H ^a   Flegg, K M ^a   Roxburgh, C S D ^a   Going, J J ^a   Mohammed, Z ^a   Horgan, P G ^a   McMillan, D C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

colorectal cancer; inflammation; invasive margin; peritumoural; survival; systemic inflammatory response

Indexed keywords

TUMOR NECROSIS FACTOR;

AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CELL INFILTRATION; CLINICAL ASSESSMENT; COLORECTAL CANCER; CORRELATIONAL STUDY; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUTROPHIL; PERITUMORAL INFLAMMATION; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

COLORECTAL NEOPLASMS; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MALE; NEOPLASM INVASIVENESS; NEUTROPHILS; PLASMA CELLS;

EID: 84862025685     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.211     Document Type: Article

References (28)

1. Baeten CI, Castermans K, Hillen HF, Griffioen AW (2006) Proliferating endothelial cells and leukocyte infiltration as prognostic markers in colorectal cancer. Clin Gastroenterol Hepatol 4(11): 1351-1357 (Pubitemid 44716741)
2. Cianchi F, Messerini L, Palomba A, Boddi V, Perigli G, Pucciani F, Bechi P, Cortesini C (1997) Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging? Dis Colon Rectum 40(10): 1170-1175
3. Fleming ID, Cooper J, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbro JW. (eds) (1997) AJCC 5th Edition Cancer Staging Manual. Lippincott-Raven: Philadelphia
4. Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R (2007) High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 13(5): 1472-1479 (Pubitemid 46450437)
5. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795): 1960-1964 (Pubitemid 44498003)
6. Goedegebuure PS, Eberlein TJ (1995) The role of CD4 + tumor-infiltrating lymphocytes in human solid tumors. Immunol Res 14(2): 119-131
7. Going JJ (2006) Counting cells made easier. Histopathology 49(3): 309-311
8. Gottfried E, Kunz-Schughart LA, Weber A, Rehli M, Peuker A, Müller A, Kastenberger M, Brockhoff G, Andreesen R, Kreutz M (2008) Expression of CD68 in non-myeloid cell types. Scand J Immunol 67(5): 453-463 (Pubitemid 351519391)
9. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K (2007) Inflammationbased prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246(6): 1047-1051 (Pubitemid 350179198)
10. Jass JR, Love SB, Northover JM (1987) A new prognostic classification of rectal cancer. Lancet 1(8545): 1303-1306 (Pubitemid 17072200)
11. Klintrup K, Mäkinen JM, Kauppila S, Väre PO, Melkko J, Tuominen H, Tuppurainen K, Mäkelä J, Karttunen TJ, Mäkinen MJ (2005) Inflammation and prognosis in colorectal cancer. Eur J Cancer 41(17): 2645-2654 (Pubitemid 41607555)
12. Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411(6835): 375-379
13. McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67(3): 257-262
14. Menon AG, Janssen-van Rhijn CM, Morreau H, Putter H, Tollenaar RA van de Velde CJ, Fleuren GJ, Kuppen PJ (2004) Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest 84(4): 493-501 (Pubitemid 41656477)
15. Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, Loddenkemper C (2007) Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med 5: 62
16. Nagtegaal ID, Marijnen CA, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJ, van Krieken JH (2001) Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect-a histopathological and immunohistochemical study. BMC Cancer 1: 7
17. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998) CD8 + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58(16): 3491-3494 (Pubitemid 28376536)
18. Oberg A, Samii S, Stenling R, Lindmark G (2002) Different occurrence of CD8 +, CD45R0 +, and CD68 + immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors. Int J Colorectal Dis 17(1): 25-29 (Pubitemid 41398987)
19. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353(25): 2654-2666 (Pubitemid 41817714)
20. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1): 71-78 (Pubitemid 38082155)
21. Prall F, Dührkop T, Weirich V, Ostwald C, Lenz P, Nizze H, Barten M (2004) Prognostic role of CD8 + tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability. Hum Pathol 35(7): 808-816 (Pubitemid 38903073)
22. Richards CH, Roxburgh CS, Anderson JH, McKee RF, Foulis AK, Horgan PG, McMillan DC (2011) Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer. Br J Surg 99(2): 287-294
23. Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6(1): 149-163
24. Roxburgh CS, McMillan DC (2011) The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev; e-pub ahead of print 24 September 2011; doi: 10.1016/j.ctrv.2011.09.001
25. Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC (2009) Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer. Eur J Cancer 45(12): 2138-2145
26. Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B (2009) Tumor-infiltrating FOXP3 + T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27(2): 186-192
27. Sandel MH, Dadabayev AR, Menon AG, Morreau H, Melief CJ, Offringa R, van der Burg SH, Janssen-van Rhijn CM, Ensink NG, Tollenaar RA, van de Velde CJ, Kuppen PJ (2005) Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization. Clin Cancer Res 11(7): 2576-2582 (Pubitemid 40569456)
28. Zlobec I, Lugli A (2009) Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 15(47): 5898-5906